PRAXBIND sol inj 2.5 g/50ml 2 flac 50 ml

7680658040011 CH-65804 V03AB37 06.99.0.
PRAXBIND sol inj 2.5 g/50ml 2 flac 50 ml
PRAXBIND sol inj 2.5 g/50ml 2 flac 50 ml
PRAXBIND sol inj 2.5 g/50ml 2 flac 50 ml
1 / 3
google

Details

Product number
6580401
CPT
-
Packaging group
2x50 ml
Unit
Durchstechflasche(n)
Composition
idarucizumabum 2500 mg, acidum aceticum glaciale, polysorbatum 20, natrii acetas trihydricus corresp. natrium 24.98 mg, sorbitolum 2004.2 mg, aqua ad iniectabile q.s. ad solutionem pro 50 ml.

Articles (1)

Praxbind 2.5 g, Injektions- bzw. Infusionslösung
Infusionslösung
2x50 ml
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
07/07/2021
Professional SmPC
Français
07/07/2021
Professional SmPC
Italien
07/07/2021

Detailed composition

Substance Quantity Type Category
(N/A)
2500.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
24.98 MG Substance HBESI
(N/A)
2004.2 MG Substance HBESI
(N/A)
- Substance HNIDK

Authorization holder

Boehringer Ingelheim (Schweiz) GmbH

4057 Basel

Authorization information

Swissmedic authorization number
65804
Drug name
Praxbind, Injektions- bzw. Infusionslösung
Galenic form
LSPA
ATC Code
V03AB37
Authorization status
Z
Dispensation category
A
First authorization
20/07/2016
Authorization expiration date
31/12/9999
IT number
06.99.0.
Domain
Human medicine
Field of application
Praxbind ist zur Aufhebung der antikoagulativen Wirkung von Pradaxa bestimmt

Packaging details

Description (FR)
PRAXBIND sol inj 2.5 g/50ml 2 flac 50 ml
Description (DE)
PRAXBIND Inj Lös 2.5 g/50ml 2 Durchstf 50 ml
Market launch
20/07/2016
Narcotic (BTM)
No